M K Proteins Limited (MKPL) AI Stock Analysis

M K Proteins Limited

(NSE:MKPL)

Select Model

Rating:48Neutral

Price Target:INR 4.00▲(4.99% Upside)

Action:reiterated

Date:09/06/26

M K Proteins Limited receives a below-average score of 48. The most significant drags on the stock are its severe margin compression and declining net income, coupled with a lofty valuation (P/E of 32.2) and a strong bearish technical downtrend. While the company's balance sheet remains a bright spot with solid equity and low leverage, it is not enough to offset the pressing operational weaknesses and negative market momentum.

Positive Factors

Revenue ReboundThe strong FY2026 sales rebound shows the business can regain demand after weaker years. Sustained revenue growth would improve operating leverage and provide a larger base from which to rebuild profitability.

Negative Factors

Severe Margin CompressionThe sharp decline in gross and net margins signals weaker pricing power, higher costs, or an unfavorable mix. Unless margins stabilize, additional revenue may translate into limited earnings and weaker resilience.

M K Proteins Limited (MKPL) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 1.48B
Dividend Yield: ―
Average Volume (3M): 20.81K
Price to Earnings (P/E): 29.5
Beta (1Y): 1.07
Revenue Growth: 17.76%
EPS Growth: -50.16%
Country: India
Employees: 54
Sector: General
Sector Strength: 55
Industry: Packaged Foods

M K Proteins Limited Business Overview & Revenue Model

Company Description

M. K. Proteins Limited specializes in the production and commercial activities related to a range of refined vegetable oils and their associated derivatives. The company's diverse offerings include refined varieties such as rice bran, sunflower, cott...

M K Proteins Limited Financial Statement Overview

Summary

M K Proteins boasts a highly resilient balance sheet with low leverage and consistent equity accumulation. However, this is heavily offset by severe profitability headwinds, aggressive margin compression, and highly unpredictable cash flow generation despite strong top-line revenue growth.

Income Statement

45Neutral

Balance Sheet

82Very Positive

Cash Flow

38Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	3.83B	3.83B	2.68B	2.46B	3.15B	2.56B
Gross Profit	107.65M	144.45M	156.53M	192.91M	180.64M	186.78M
EBITDA	85.46M	116.77M	129.08M	170.99M	176.52M	157.88M
Net Income	46.98M	68.29M	83.97M	112.12M	109.35M	101.84M
Balance Sheet
Total Assets	0	1.31B	1.31B	962.46M	1.03B	861.48M
Cash, Cash Equivalents and Short-Term Investments	4.38M	4.38M	338.00K	923.24K	624.84K	66.62K
Total Debt	0	371.38M	387.24M	200.83M	455.35M	367.84M
Total Liabilities	-763.00M	548.97M	611.04M	351.70M	533.55M	465.44M
Stockholders Equity	763.00M	763.00M	694.66M	610.76M	498.64M	396.04M
Cash Flow
Free Cash Flow	0	19.10M	-183.51M	265.13M	-58.80M	-116.95M
Operating Cash Flow	0	38.05M	-161.28M	324.16M	-58.73M	-101.22M
Investing Cash Flow	0	-17.18M	-14.82M	-58.78M	133.85K	-15.28M
Financing Cash Flow	0	-16.83M	175.52M	-265.08M	59.15M	116.56M

M K Proteins Limited Technical Analysis

Technical Analysis SentimentNeutral

Last Price3.81

Price Trends

50DMA3.99Negative

100DMA4.25Negative

200DMA4.71Negative

Market Momentum

MACD-0.07Positive

RSI51.20Neutral

STOCH40.56Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MKPL, the sentiment is Neutral. The current price of 3.81 is below the 20-day moving average (MA) of 3.90, below the 50-day MA of 3.99, and below the 200-day MA of 4.71, indicating a neutral trend. The MACD of -0.07 indicates Positive momentum. The RSI at 51.20 is Neutral, neither overbought nor oversold. The STOCH value of 40.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:MKPL.

M K Proteins Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:MKPL against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:GOKULAGRO	73Outperform	INR 63.44B	13.60	―	―	21.04%	59.07%
IN:KRITINUT	61Neutral	INR 3.33B	9.70	―	0.45%	21.14%	3.47%
IN:GOKUL	59Neutral	INR 3.43B	16.39	―	―	15.39%	27.60%
IN:MUKKA	58Neutral	INR 7.38B	10.54	―	―	76.01%	59.13%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:ROML	54Neutral	INR 631.87M	13.57	―	―	20.89%	-11.15%
IN:MKPL	48Neutral	INR 1.48B	29.54	―	―	17.76%	-50.16%

* General Sector Average

Performance Comparison

IN:MKPL and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:MKPL	M K Proteins Limited	3.75	-2.98	-44.28%
IN:GOKUL	Gokul Refoils & Solvent Ltd.	34.94	-6.06	-14.78%
IN:GOKULAGRO	Gokul Agro Resources Ltd.	214.35	39.00	22.24%
IN:KRITINUT	Kriti Nutrients Limited	65.62	-20.61	-23.90%
IN:MUKKA	Mukka Proteins Limited	24.41	-0.58	-2.32%
IN:ROML	Raj Oil Mills Limited	46.52	-4.68	-9.14%

M K Proteins Limited Corporate Events

M K Proteins Closes Trading Window Ahead of Q1 FY2026 Results

Jun 27, 2026

M K Proteins Limited has announced the closure of its trading window for company shares starting 1 July 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and its own code of conduct, covering employees, directors, key manager...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026

M K Proteins Limited AI Stock Analysis